Tesa-CJC-Ipa is a pre-mixed vial of tesamorelin, CJC-1295 and ipamorelin: two GHRH analogues and one ghrelin receptor agonist. No clinical trial has studied the blend.
Tesamorelin is the full 44-amino-acid sequence of human GHRH with a hexenoyl group attached, sold as Egrifta (Egrifta WR label). CJC-1295 is a modified GRF(1-29) built by ConjuChem in 2005 to bind albumin and last for days (Jetté et al., 2005). Ipamorelin is a Novo Nordisk pentapeptide that released growth hormone in animals without raising ACTH or cortisol (Raun et al., 1998).
Tesamorelin has the strongest record of the three: its label rests on two multicenter, randomized, placebo-controlled studies in HIV patients with excess abdominal fat. CJC-1295 has two small trials in healthy adults (Teichman et al., 2006), and ipamorelin’s phase 2 surgical trial found no significant difference from placebo (Beck et al., 2014). As of October 2026, ClinicalTrials.gov lists no registered trial combining any two of these peptides.
Only tesamorelin is FDA-approved, for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. The blend is unapproved, and WADA bans all three components.
The FDA approved tesamorelin in November 2010; its current label limits use to HIV-infected adults with lipodystrophy and states it is not indicated for weight loss (DailyMed). CJC-1295 and ipamorelin have no FDA approval, and the FDA placed ipamorelin acetate in 503B compounding category 2 in 2023 (FDA). WADA’s 2026 list names tesamorelin and CJC-1295 as GHRH analogues and ipamorelin as a growth hormone secretagogue under S2.2.4 (WADA).
Three peptides make three identity questions. Tesamorelin and CJC-1295 are both GHRH analogues, so a vial short on one and heavy on the other can look similar on paper unless each is identified and quantified separately. A useful certificate names all three components and reports a measured amount for each.
Check a batch’s published result before trusting its label. Recent certificates are on our latest tests page, and Janoshik’s public results database lets you look up a specific test. No published results for Tesa-CJC-Ipa are in our index yet. When the first published result arrives, a vendor leaderboard appears above.